Search
Search the current U.S. Code within Title 21
Search by citation or keyword across the current edition within Title 21.
21 U.S.C. § 355c
Research into pediatric uses for drugs and biological products
Research into pediatric uses for drugs and biological products
21 U.S.C. § 360cc
Protection for drugs for rare diseases or conditions
Protection for drugs for rare diseases or conditions
21 U.S.C. § 356
Expedited approval of drugs for serious or life-threatening diseases or conditions
Expedited approval of drugs for serious or life-threatening diseases or conditions
21 U.S.C. § 353
Exemptions and consideration for certain drugs, devices, and biological products
Exemptions and consideration for certain drugs, devices, and biological products
21 U.S.C. § 353d
Process to update labeling for certain generic drugs
Process to update labeling for certain generic drugs
21 U.S.C. § 355f
Extension of exclusivity period for new qualified infectious disease products
Extension of exclusivity period for new qualified infectious disease products
21 U.S.C. § 811
Authority and criteria for classification of substances
Authority and criteria for classification of substances
21 U.S.C. § 355d
Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers